Abstract
Objective: To assess whether the modified Scopinaro surgery is as effective and safe as the classic Scopinaro surgery to reduce excess weight, control the comorbidities, and evaluate the onset of clinical and nutritional intercurrences, if any. Methods: The study sample was composed of 28 participants who were randomized to undergo one of the surgical procedures, and who were monitored by a multiprofessional health team to evaluate the impact of the surgery in the treatment of obesity. We assessed the following variables: comorbidities, clinical and nutritional intercurrences and quality of life. The research protocol was approved by the Ethics in Research Committee of Faculdades Integradas de Pitágoras de Montes Claros (under CAAE 26919414.9.0000.5109). All of the participants signed the informed consent form (ICF). Results: The mean pre-surgery body mass index (BMI) for the classic Scopinaro group and the modified Scopinaro group was of 46.89 kg/m2 and 43.22 kg/m2 respectively. After 540 days of the surgery, these values dropped to 32.16 kg/m2 and 28.79 kg/m2. The evaluation of the percentage of excess BMI lost (%EBL) in the period proved the surgical success, with values of 67.33%% for the classic Scopinaro surgery, and of 80.37% for the modified Scopinaro surgery. Control of the comorbidities, as well as a general improvement in the laboratory test results, was achieved by most of the participants subjected to either one of the techniques. Flatulence and diarrhea were the clinical intercurrencesfound as a result of both procedures. Conclusion: We concluded that the modified Scopinaro surgery is as effective and safe as the classic Scopinaro surgery in reducing weight and in the control of comorbidities, and it also presents the possibility of endoscopic access of all of the stomach and duodenum, surgical reversibility, and conversion into another surgical procedure.
Metrics
References
- Ellulu M, Abed Y, Rahmat A, Ranneh Y, Ali F. Epidemiology of obesity in developing countries: challenges and prevention. Global Epidemic Obesity. 2014; 2 (01) 1-6
- Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013; 93 (01) 359-404
- Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am 2010; 39 (01) 1-7
- Kaila B, Raman M. Obesity: a review of pathogenesis and management strategies. Can J Gastroenterol 2008; 22 (01) 61-68
- Sippel C, Bastian RMA, Giovanella J, Faccin C, Contini V, Dal Bosco SM. Processos inflamatórios da obesidade. Revista de Atenção à Saúde 2014; 12 (42) 48-56
- Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg 2007; 17 (05) 565-568
- Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117 (05) 701-706
- Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol 2011; 8 (08) 429-437
- Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014; 311 (01) 74-86
- Kashyap SR, Bhatt DL, Wolski K. , et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 2013; 36 (08) 2175-2182
- Scopinaro N, Gianetta E, Adami GF. , et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996; 119 (03) 261-268
- Scopinaro N, Gianetta E, Pandolfo N. , et al. Biliopancreatic diversion. Minerva Clin. 1976; 31: 560
- Baker MT. The history and evolution of bariatric surgical procedures. Surg Clin North Am 2011; 91 (06) 1181-1201 , viii
- Domene CO, Volpe P, Puzzo DB, Pimente MP, Camargo RB. Derivação bliopancreática com preservação gástrica videolaparoscópica para tratamento da obesidade mórbida. Rev Bras Videocir. 2005; 3 (03) 143-151
- Mason EE, Tang S, Renquist KE. , et al; National Bariatric Surgery Registry (NBSR) Contributors. A decade of change in obesity surgery. Obes Surg 1997; 7 (03) 189-197
- Linner JR, Drew RL. Technique of anterior wall Roux-en-Y gastric bypass for the treatment of morbid obesity. Contemp Surg 1985; 26: 46-59
- Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg 1998; 8 (05) 487-499
- Oria HE, Moorehead MK. Updated Bariatric Analysis and Reporting Outcome System (BAROS). Surg Obes Relat Dis 2009; 5 (01) 60-66
- Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005; 15 (03) 408-416
- Gomez CA. Gastroplasty in morbid obesity. Surg Clin North Am 1979; 59 (06) 1113-1120
- Manson EE. Gastroplasty. Major Probl Clin Surg 1981; 26: 1-386
- Manson EE. Surgical treatment of obesity. Philadelphia: WB Saunders Co.; 1981: 493
- Pace WG, Martin Jr EW, Tetirick T, Fabri PJ, Carey LC. Gastric partitioning for morbid obesity. Ann Surg 1979; 190 (03) 392-400
- MINISTÉRIO DA SAÚDE. 2015. Metade dos brasileiros está com excesso de peso [acesso em 1 jul 2015]. Disponível em: http://www.brasil.gov.br/saude/2015/04/metade-dos-brasileiros-esta-com-excesso-de-peso
- Buchwald H, Avidor Y, Braunwald E. , et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292 (14) 1724-1737
- ABESO. Diretrizes brasileiras de obesidade 2009/2010. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica 2009 [acesso em 14 set 2005]. Disponível em: http://www.abeso.org.br/pdf/diretrizes_brasileiras_obesidade_2009_2010_1.pdf
- Bastos EC, Barbosa EM, Soriano GM, dos Santos EA, Vasconcelos SM. Determinants of weight regain after bariatric surgery. Arq Bras Cir Dig 2013; 26 (Suppl. 01) 26-32
- Sarmento R, Casagrande D, Schaan B. Cirurgia bariátrica no tratamento da obesidade: impacto sobreo metabolismo ósseo. Revista HUPE 2014; 13 (01) 87-93
- Michielson D, Hendrickx L, Hendrickx L. Complications of biliopancreatic diversion surgery as proposed by Scopinaro in the treatment of morbid obesity. Obes Surg 1996; 6 (05) 416-420
- Dolan K, Hatzifotis M, Newbury L, Lowe N, Fielding G. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg 2004; 240 (01) 51-56
- Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8 (03) 267-282
- Marceau P, Biron S, Hould FS. , et al. Duodenal switch: long-term results. Obes Surg 2007; 17 (11) 1421-1430
- Baltasar A, Bou R, Miró J, Bengochea M, Serra C, Pérez N. Laparoscopic biliopancreatic diversion with duodenal switch: technique and initial experience. Obes Surg 2002; 12 (02) 245-248
- Santoro S, Velhote MCP, Malzoni CE, Mechenas ASG, Damiani D, Makskoud JG. Digestive adaptation with intestinal reserve: a new surgical proposal for morbid obesity. Rev Bras Videocir. 2004; 2 (03) 130-138